HALO-Surgery
Research type
Research Study
Full title
Home And Locally Observed after Surgery
IRAS ID
284073
Contact name
John Kelly
Contact email
Sponsor organisation
University College London
Clinicaltrials.gov Identifier
N.A., N.A.
Duration of Study in the UK
2 years, 0 months, 30 days
Research summary
The UCLH Cancer Hub has been in operation since lock down to enable surgery for patients with cancer to take place in a COVID-19-free environment. However, there is a reduction in staffing resources as clinical staff are redeployed to the frontline, and thus affecting how patients are managed post-discharge. Our centre’s standard of care during this pandemic is to provide patients with pulse oximeters on discharge, and a daily conversation with a member of the surgical team for a period after discharge from hospital. However, a one-off oximeter reading has its limitations in detecting an early functional decline and surgical complications, hence there is a need to enhance current post-discharge management of patients.
We have developed HALO (Home and Locally Observed), a home monitoring device for which we have assessed the feasibility of using smart technology to collect physiological and patient-reported outcome measures (PROMs) in patients following discharge from hospital after major intra-cavity surgery. Compliance testing with patients has been conducted with positive feedback. The next stage of the testing would involve analysis of sensor data that can be used to alert the surgical team to a change in status consistent with a deterioration and if necessary further management of assessment can be instigated. Therefore, the aim of this study is to assess the heart rate and activity data collected by HALO can be used to detect patient deterioration remotely for the first 30 days post- when compared with standard of care monitoring.
REC name
Wales REC 6
REC reference
20/WA/0221
Date of REC Opinion
10 Aug 2020
REC opinion
Further Information Favourable Opinion